See Cart

Products

FeNO by NIOX®

Fraction of Exhaled Nitric Oxide (FeNO)

The experts at Carolina Diagnostic Solutions offer a wide range of screening and diagnostic devices for asthma care to provide comprehensive and easy-to-use testing in conjunction with spirometry.

Our primary goal is to increase the quality of care provided and, in turn, the quality of life for the patients we serve.

We work directly with healthcare organizations and primary care physicians to train employees to maximize pulmonary care for patients.

TRANSFORM ASTHMA CARE

Asthma: it's all about the inflammation

Asthma is caused by airway inflammation, but conventional tests like spirometry are checking for obstruction rather than inflammation. That's why it is SO important to have FeNO in your practice. (1-3)

More accurate diagnosis and better management (6-8) 
Asthma is seven times more likely when FeNO is >40 ppb (9). Up to a 50% reduction in exacerbations with FeNO. (10)

 

Contact us today to find out more about FeNO options for your organization. 

 

 

 

References: 1. Smith et al. Am J Respir Crit Care Med. 2004. 2. Hanania et al. Ann Allergy Asthma Immunol. 2018. 3. Busse et al. Lancet Respir Med. 2021. 4. Asthma & Allergy
Foundation of America. Available at; https://aafa.org/asthma/asthma-facts/. Accessed; July 2023. 5. Alving et al. Pulm Ther. 2017. 6. Menzies-Gow et al. Eur Respir J. 2020. 7. Price et
al. Lancet Respir Med. 2017. 8. Sabatelli et al. J Investig Allergol Clin Immunol. 2017. 9. Wang et al. Comparative E ect Rev, 197. 2017. 10. Petsky et al. Thorax. 2018. 11. NIOX®. Data on
File; MKT-DOF-007. 2023. 12. Gao et al. Allergy Asthma Clin Immunol. 2018. 13. NIOX®. Data on File; MKT-DOF-005. 2023.
Copyright NIOX Group plc 2023 - NIOX® and NIOX VERO® are registered trademarks of Circassia AB. MKT-PRM-US-0025.

INDUSTRY PARTNERS